StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com

Nasdaq Files Form 25 to Delist Vesicor Therapeutics Units and Rights

Nasdaq filed a Form 25 to remove Vesicor Therapeutics Holdings' units and rights from listing, as the stock fell 71% on more than 20 times its normal volume.

What happened

Nasdaq Stock Market LLC filed a Form 25 with the SEC on Nov. 20, 2026, to remove a class of securities of Vesicor Therapeutics Holdings, Inc. from listing and registration. The filing describes the affected class as "Unit and Rights."

The filing does not state which of the four rule provisions it checked to justify the delisting, and it does not describe a reason for the removal. A separate box on the form covers voluntary withdrawals by the issuer, but it is not possible to tell from the text provided which basis applies.

Vesicor Therapeutics Holdings is listed in SEC records under the industry category Biological Products (No Diagnostic Substances), meaning it develops biologic drugs rather than conventional chemical pills. Its principal offices are in Danville, California.

The filing came on a day when the stock closed at $1.85, down 71.45% from the prior close of $6.48. Volume was 2,113,600 shares, about 21.7 times the average of 97,218.

The price move

The decline and the heavy volume are facts from the price data, not an explanation. The sources provided do not say what caused the drop, and this article does not attribute a cause.

The shares that traded are presumably the underlying common stock rather than the units and rights named in the Form 25, but the filing does not address the common stock's status.

What this means

A Form 25 is the formal notice that removes a security from an exchange listing and from registration under Section 12(b) of the Securities Exchange Act of 1934. Either the company or the exchange can file it. Here Nasdaq filed it, and the signatory is Katelin Rowe, a CDO Analyst at the exchange.

The form asks the filer to check one of four rule provisions under 17 CFR 240.12d2-2. The text provided does not show which box was marked, so the specific trigger — for example, a failure to meet a listing standard — cannot be confirmed from these sources.

The security named is "Unit and Rights." A unit is a bundle of securities sold together, often a share plus a warrant to buy more stock later. A right is a short-term entitlement to buy new shares, usually in a follow-on offering. Delisting units and rights is therefore narrower than delisting common stock, though in practice such securities often trade alongside the shares.

Delisting and deregistration are separate from a company's obligations under the securities laws. A company whose stock leaves Nasdaq can still have reporting duties, and its shares can trade over the counter. The filing does not say what the company plans next, and the sources do not establish why the delisting occurred.

Sources

Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.